Stockreport

Fulcrum hits 52-week high as CEO buys shares [Seeking Alpha]

Fulcrum Therapeutics, Inc.  (FULC) 
Last fulcrum therapeutics, inc. earnings: 3/5 07:00 am Check Earnings Report
PDF According to an SEC submission filed Tuesday, Sapir, who assumed FULC's leadership in July 2023, has bought ~43.4K company shares for a weighted average price of $11.35 [Read more]